Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy.
Badr Eslam R, Öztürk B, Rettl R, Capelle CDJ, Qin H, Binder C, Dachs TM, Camuz Ligios L, Duca F, Dalos D, Schrutka L, Alasti F, Kastner J, Vila G, Bonderman D.
Badr Eslam R, et al. Among authors: alasti f.
Circ Heart Fail. 2022 Jul;15(7):e008381. doi: 10.1161/CIRCHEARTFAILURE.121.008381. Epub 2022 Jun 29.
Circ Heart Fail. 2022.
PMID: 35766028